Osteoarthritis injection may affect metabolism in diabetes

Access to the full content of this site is available only to registered healthcare professionals. Register to read more


  • Intra-articular corticosteroid injection (IACI) of betamethasone (eg, Celestone Soluspan) for knee osteoarthritis increases blood glucose, insulin, and insulin resistance in patients with type 2 diabetes (T2D).

Why this matters

  • Clinicians prescribing IACI should be aware of...